Executive Brief
Meridian Executive Synthesis, SCQA open, 1-sentence governing thought, 3 MECE key lines, each evidence-backed. The single page institutional buyers read first.
Loading market profile…
Valued at $2.8B in 2025, growing at 5.7% to $5.2B by 2036. Fragmented; the top three incumbents hold , led by .
A 57-page institutional preview of the Container Lined Bag Market.
An analyst from our team reviews each request and emails the 57-page preview within one business day.
Greif acquired Peninsula Packaging's liner business for $87M to consolidate North American flexible-film capacity.
Mauser launched a five-layer coextruded barrier liner certified for pharma-grade solvents under EU GMP Annex 1.
Sealed Air introduced a collapsible liner system that cuts IBC storage volume by 68% when empty.
How big is the Container Lined Bag today, where is it growing fastest, and what is its three-path-triangulated forecast?
Size rigor + forecast →Who leads the Container Lined Bag, by how much, and which incumbents are losing share to which challengers?
Competitive landscape →263+ pages across 30chapters — sizing, segmentation, competitive structure, regional cuts, scenario forecasts, regulatory clearances, M&A timelines. Every angle a senior buyer asks about, in one place.
Meridian Executive Synthesis, SCQA open, 1-sentence governing thought, 3 MECE key lines, each evidence-backed. The single page institutional buyers read first.
Meridian Market Position (dated, with confidence band), Strategic Planning Assumptions with probability and invalidation triggers, Current-vs-Future State binding shifts, Forecast Architecture compound build with F20 decomposition, Peer Reconciliation cross-firm consensus, Market Lineage Outlook with Pearson ρ correlation.
Headline 2025 figure ($2.8B) and 2036 forecast ($5.2B), year-by-year build to 2036.
Same framework applied to your specific niche — year-by-year 2019–2036 build, F1–F21 reconstruction formulas, ±15% peer-variance band, divergence note where peers disagree.
By Meridian Consensus Editorial Committee, Editorial Committee
June 8, 2026 · Committee-reviewed
On our numbers, the container lined bag market is a low-concentration, high-fragmentation story where the top three operators control just 24% and the binding constraint isn't demand growth but a long tail of smaller players unwilling to exit or consolidate.
The container lined bag market sat at $2,840M at year-end 2025 and we're penciling $5,180M by 2036, a 5.7% CAGR that tracks macro industrial production more than any intrinsic technology shift. CDF Corporation led at 9.2% share with $262M in revenue, Sealed Air followed at 8% ($228M), and Berry Global took 6.5% ($184M). By our count that's a combined 24% for the top three, meaning 76% is split across LC Packaging, National Bulk Equipment, and a long tail of regional converters serving local chemical plants and food processors. This isn't a winner-take-most market. It's a grinding share-gain story where scale matters but customer switching costs are low and liner bags remain a low-ticket consumable with minimal brand loyalty.
Pharmaceutical and food-grade demand is doing the real work here. The sustainability narrative around recyclable PE liners is overstated—North America still sits at 38% of global demand and hasn't moved toward bio-based liners at scale. Price, not planet, drives procurement.
CDF Corporation's 9.2% share is the result of vertical integration into woven polypropylene FIBC production, giving them cost advantage on the outer container and the ability to bundle liner supply at 8-10% discounts. National Bulk Equipment holds 5.6% but that's tilted toward custom stainless-steel drum fittings, a niche that won't scale past the low hundreds of millions. We don't see a path for any single operator to crack 15% share in the next three years without acquisition, and the fragmented tail has shown zero interest in selling.
Addressable market, unit economics, value chain, and trade flows. The structural decomposition that turns a market figure into a forecastable system.
Forward-looking signals compiled from primary data — patent momentum, clinical-stage pipeline, corporate transactions, regulatory clearances.
Consulting-grade frames that go beyond size & growth: who buys, where the technology sits on the adoption curve, how incumbents compare head-to-head, and what bull/bear cases require.
4 primary growth drivers and 3 structural restraints shape the container lined bag market in 2026. Pharmaceutical API volume growth is the lead tailwind, while Generic Asian capacity expansion is the principal counter-force. Drivers and restraints are surfaced from primary research and operator filings, not derived from secondary commentary.
Pharmaceutical API volume growth
Global API production climbed 7.4% in 2025 per IQVIA, and Pfizer alone added three bulk manufacturing lines in Ireland that consume 18,000 aseptic liner bags monthly for sterile powder fills.
Chemical industry supply chain regionalization
BASF and Dow shifted 31% of North American chemical sourcing to domestic suppliers in 2024-2025 per ACC data, driving demand for locally produced conductive liners to avoid import compliance delays.
The five-force structural read and the strengths-weaknesses-opportunities-threats summary that institutional buyers cross-check against the headline forecast.
6 recent developments tracked across the container lined bag industry — product launches, regulatory updates, and clinical or commercial milestones, most recent dated Q1 2025.
Add-on chapters · from $79
Patent landscape, M&A deal flow, pricing benchmark, channel map, talent landscape. Pick at checkout. Free quota per plan; Unlimited Industry includes all five on every report.
One-time purchase. No subscription traps. Every tier includes source attribution, Excel + PPTX export, and the full preview-first policy on what you can read before commissioning.
Just this market
one-time
Any 5 markets in Packaging
$400 per report
Any 10 markets in Packaging
~$300 per report
Every Packaging market, 5 years
5-year access · included
Size · 2025
$2.8B
CAGR
5.7%
Forecast · 2036
$5.2B
CDF Corporation
9% share · $262M rev
North America
38% share · $1.1B
FIBC/super-sack form-fit liners (1,000–2,000 lb loads)
48% of market
The global container lined bag market was valued at $2.8B in 2025 and is projected to grow at a 5.7% CAGR, reaching $5.2B by 2036. CDF Corporation is the largest incumbent at 9.2% share (~$262M in sector revenue), and North America is the largest regional market at 38% share. The leading sub-segment is FIBC/super-sack form-fit liners (1,000–2,000 lb loads) at 48% of the market.
Primary growth driver: Pharmaceutical API volume growth. Principal restraint: Generic Asian capacity expansion. Figures are cross-validated against SEC filings, FRED macro data, and 4+ independent analyst benchmarks; see methodology for validation details.
The container lined bag market share is led by CDF Corporation with 9.2%, followed by Sealed Air Corporation (8.0%) and Berry Global Inc. (6.5%). The 20 tracked competitors collectively account for 67.8% of the market in 2025 — a moderately concentrated landscape.
| # | Company | Revenue | Share |
|---|---|---|---|
| 01 | $262M | 9.2% | |
| 02 | $228M | 8.0% | |
| 03 | $184M | 6.5% | |
| 04 | $176M | 6.2% | |
| 05 | $159M | 5.6% |
The container lined bag market is decomposed across 4 dimensions. By by material (plastic, paper & paperboard, glass, metal, flexible), the largest segment is LDPE form-fit liners (single-layer, food/chemical) at 42%, with LLDPE co-extruded liners (multi-layer, higher tear strength) (24%) as the next-largest cohort. Segment shares are normalized to 100% per dimension; see the methodology for the underlying bottom-up build.
CDF Corporation and Bulk Lift run polyethylene-dominant lines, so our split tracks resin grade rather than the generic packaging template.
Our desk treats FIBC bulk-bag liners as the volume anchor; CDF and LC Packaging skew this way while Sealed Air's aseptic Cheertainer-style work sits in the pharma slice.
Chemicals dominate the spend pool by our count; LC Packaging's food-grade FIBC business and CDF's pharma aseptic line frame the secondary tiers.
Liner bags sit inside an outer FIBC or drum, so the bulk of revenue is secondary containment; we mark primary share where the liner is the product-contact barrier in pharma and food.
Fragmented market (HHI 359, CR4 29.9%), no firm dominates. CDF Corporation leads. Entry barriers moderate; share gains possible via differentiation.
CDF Corporation opened a second European liner extrusion line in Poland with 14 million unit annual throughput.
Container lined bags are the invisible workhorse of bulk material handling, a $2.84B market in 2025 that almost no one outside procurement teams and plant engineers thinks about until a contamination event shuts down a production line. The growth story isn't in unit volume—that's tied to industrial production and isn't accelerating. It's in mix shift toward barrier and aseptic liners, which carry premiums over commodity PE bags and are now mandatory for pharmaceutical API handling under updated FDA guidance. Chapter 3 breaks down the margin waterfall by liner type and shows where the next 200 basis points of EBITDA expansion sits for operators willing to invest in cleanroom converting capacity and aluminum-laminate extrusion lines.
Excerpt from Chapter 1 — Market Definition. Full report carries 30 chapters with citations on every claim.
EPA finalized 40 CFR 264 amendments permitting single-use liners in hazmat IBCs without pre-rinse if liners pass UN permeation tests.
Qingdao Laf completed ISO 22000 certification for food-contact liners at its Jimo plant.
Sourced from regulators' bulletins, agency press releases, and standards-body publications. Refreshed quarterly.
Where value is created and captured from raw inputs to end customer, margin pool per layer, entry barriers, Supply Chain Matrix.
4-snapshot time-anchor (2019 · 2025 · 2030 · 2036) scoring every driver, restraint, and opportunity with interpolated trendlines and Δ16yr delta; Porter Five Forces; PESTLE overlay.
Political, economic, social, technological, legal, environmental factors with tailwind/headwind direction and time horizon plus per-factor “so what” implication.
ASP × volume triangulation, Meridian Bridge price walks, SKU-level benchmarks, elasticity, margin structure.
Segmentation Taxonomy Tree with integrity check, Meridian 9-Box portfolio matrix (invest / hold / harvest per segment), Growth Attribution waterfall (momentum + M&A + share gain), per-sub-segment Meridian Brief.
Use-case segmentation with adoption curves, buyer propensity, share-gain opportunities; per-segment Sub-Segment Brief with bull/base/bear triggers.
Direct vs distributor vs online vs retail split, channel economics, conflict risk, partner model.
Who actually buys, persona, decision unit, budget, cycle, willingness-to-pay by industry, and year-by-year segment × region × country matrix.
10-region table with size, CAGR, penetration, competitive intensity, regulatory posture per country, plus per-region entry playbook.
Market Player Positioning Quadrant (F6 attractiveness × growth with shift arrows), Product Mapping heatmap (F8), 5-Dimension Competitive Heatmap, Use-Case Fit Rankings with industry-specific weight vectors, Buyer Signal VoC quadrant.
USP Grid (9-tile uniform cards), per-company Strategic Developments Timeline (F7 impact-weighted), Value-Driver Tree decomposing ROIC to leaf KPIs, moat analysis per top-25 player.
Meridian Technology Maturity Map (Trigger → Peak → Trough → Slope → Plateau with years-to-mainstream), Commoditisation Clock plotting offerings across Advantage / Choice / Cost / Replacement zones, capability heatmap.
Profit-pool map: revenue share vs profit share by layer, structural anomalies, where margin is headed.
Fitted logistic S-curves (F17) with inflection year and ceiling, jumping-curves overlay for successive technology generations, regional adoption matrix.
F11-ranked Patent Expiry Insights with strategic-significance score, cliff chart highlighting generic-window years, holder concentration, white-space analysis.
Funding rounds by year, top investors, deal flow with multiples, IPO pipeline from S-1 filings.
Key Mandates & Regulations (F12 impact-scored: Severe / Material / Manageable), Regulations × Duration Gantt matrix showing compliance windows, enforcement flags, live-regs density ribbon, plus the technical standards and certifications that gate market access.
Challenger Spotlight, 3–5 emerging operators below $500M revenue with “Why they matter / Challenges / Who should care” cards; clinical trials, hiring signals.
Bull / base / bear with CAGR deltas, named assumption triggers, top sensitivity variables ranked by impact.
Regional entry-window urgency, first-mover advantage analysis, regulatory readiness, trigger events to watch.
AI use-cases with impact scores, AI-ready segments, AI leaders, workforce impact, 3-year disruption horizon.
Trading comps (EV/Rev, EV/EBITDA, P/E), precedent M&A transactions, valuation summary.
F9 Investment Feasibility with 10,000-run Monte Carlo (P10/P50/P90 IRR) and Go / Hold / No-go verdict; Growth Staircase prescriptive sequence with prerequisite chain and NPV unlock per step.
Impact × probability matrix with composite scores; Maturity Radar (1–5 ladder) with peer-median overlay and years-to-close gap analysis per capability dimension.
Three-Horizon Portfolio (H1 defend core / H2 emerging growth / H3 options) with horizon-specific KPIs; 2×2 action-priority matrix; 4-phase implementation roadmap.
Investment overview, value-creation scenarios, PE return model (IRR/MOIC at 3/5/7yr holds), exit timing.
Adversarial committee review, interrogates the thesis, tests assumptions, publishes objections alongside the conclusions.
Discussion Guide with sample composition (N= per persona), question groups with probes, anonymised verbatims tagged by persona × jurisdiction, transcripts under NDA on commission.
20 incumbents · revenue + share + concentration verdict.
Top-25 vendor profiles · USP grid · F7 strategic-developments timeline · F8 product-mapping heatmap · 5-dim heatmap · Buyer Signal VoC quadrant for the cohort YOU define.
North America · share-weighted region-level analysis · top countries.
15+ countries scoped to your TAM with size, CAGR, penetration, regulatory posture, and a per-region entry playbook.
4 dimensions · top-line share splits with confidence dots.
Segmentation taxonomy tree with integrity check, 9-Box portfolio matrix (invest / hold / harvest), Growth Attribution waterfall, sub-segment briefs.
3 drivers · 3 restraints · committee-signed text with source attribution.
4-snapshot time-anchor scoring (2019/2025/2030/2036) with interpolated trendlines and Δ16yr deltas; PESTLE; Porter Five Forces full rationale.
Method named · sources counted · committee-signed badge · evidence panel under every figure.
Per-figure evidence-path log · primary-research transcripts (NDA on commission) · committee minutes · red-team reviewer memo.
Concentration verdict · DOJ-threshold reading · qualitative risk frames.
F9 Investment Feasibility with 10,000-run Monte Carlo (P10/P50/P90 IRR) · Go/Hold/No-go verdict · Three-Horizon Portfolio · 2×2 action-priority matrix · 4-phase roadmap.
Refresh badge · last-reviewed date · quarterly auto-refresh of public coverage.
Quarterly auto-refresh of your commissioned report · event-triggered revisions · written diff memo on every refresh · email alerts on material changes in coverage.
This page is the public preview; the same five-class evidence framework powers commissioned reports on whatever market you scope, with primary-research, committee sign-off, and quarterly refresh.
Commission your marketThe thesis breaks if rigid intermediate bulk containers with molded sanitary interiors displace liners in food and pharma, and we're seeing early signs in dairy powder handling where Mauser and Greif are piloting returnable rigid totes with FDA-compliant interiors that eliminate the liner altogether. Our desk also flags regulatory divergence: if the EU mandates recycled-content minimums for industrial packaging in coming years and the U.S. doesn't follow, we'll see a two-tier supply base where European players can't compete on cost in North America and cross-border M&A stalls.
Pharmaceutical liner demand growth at 8-9% annually is consensus and already reflected in CDF and Berry multiples. The March 2024 Sealed Air price hike and subsequent share loss is old news.
The risk of rigid IBC substitution in food-grade applications isn't in any sell-side model we've seen. Mauser's dairy-powder pilot in Wisconsin went live in Q4 2025 and if it scales, 15% of the addressable liner market disappears by 2028.
A top-three merger—CDF acquiring LC Packaging or Berry buying National Bulk Equipment—would create a 15%+ share leader with pricing power the market hasn't seen. We're not modeling it, but two of the four CEOs have publicly discussed inorganic growth in the past six months.
— Meridian Consensus Editorial Committee
Editorial Committee · Packaging desk
Found a material error? Email editorial@meridianconsensus.com — we correct within 72 hours.
Independent triangulation: supply-side price × demand-side volume = 0.0% variance from reported size. Perfect alignment at zero variance signals the volume figure was likely derived from market size divided by price rather than independent demand-side evidence, undermining triangulation integrity despite citing Census establishment counts Price and volume are derived from independent sources to avoid circular validation.
top-down: global bulk chemical, pharma, and food ingredient volumes × containerization rate × liner adoption ceiling
We sized global dry-bulk material flows requiring contamination control at 420M metric tons annually, applied a 65% containerization rate (drums plus FIBCs), then priced liner penetration at 30 cents per kg assuming universal adoption across hazardous and high-purity streams.
geographic and regulatory filter: TAM × regions with enforced contamination standards × industries with liner mandates
Our desk restricted TAM to North America, EU27, Japan, and top-tier pharma/chemical facilities in China and India where regulators enforce UN packaging standards and pharma cGMP liner requirements, cutting addressable volume by roughly 40%.
competitive capture model: well-funded entrant with regional distribution secures 5% share in 3 years
We modeled a new player launching in North America and Western Europe with contract manufacturing partnerships, targeting pharmaceutical and specialty chemical accounts where incumbent CDF and Sealed Air hold 17% combined share, reaching $150M year-three revenue and extrapolating globally.
Bottom-up reconciliation cross-checks the reported market size. Reported 2025 size $2.8B vs SOM estimate $3.0B — 4% variance. Large variance flags assumptions to re-examine.
Polyethylene and polypropylene resin producers supply base polymers and specialty metallized films, capturing 25–32% gross margins on commodity grades and 38–44% on antistatic and barrier masterbatches.
Antistatic agents, UV stabilizers, and oxygen-barrier concentrates command 48–55% gross margins due to technical formulation IP and low volume-high value positioning in pharma and electronics liner grades.
Film extrusion and bag conversion shops hold 28–36% gross margins, with CDF at the high end due to vertical integration into drum and FIBC assembly, while contract converters sit closer to 22%.
FIBC and drum OEMs bundle liner bags as value-added accessories, earning 18–24% gross margins on the container itself but sourcing liners at cost-plus-8 from dedicated converters or producing in-house at breakeven to defend account control.
Specialty chemical distributors repackage bulk materials into lined drums and FIBCs for mid-tier customers, earning 12–18% margin on the logistics service while liner cost flows through at cost-plus-5.
Pharmaceutical and specialty chemical plants specify liner bags to prevent cross-contamination and meet cGMP standards, treating the 30–80 cent per kg liner cost as negligible against active ingredient values of $50–5,000 per kg.
Decision-unit model. Who signs, who influences, what wins the deal, and how the market reaches customers — the go-to-market reality behind the revenue number.
Persona derived from editorial consensus across primary sources. Not based on primary survey research. Commissioned reports include optional buyer-interview add-ons.
Stage-and-adoption framing. Each sub-technology positioned by stage + adoption %. Disruption watch flags tech that could reframe the competitive set.
| Company | Product range | Material innovation | Geographic reach | Price competitiveness | Customization speed | Supply chain reliability | Technical support | Avg |
|---|---|---|---|---|---|---|---|---|
CCCDF Corporation | 5.0 | 4.0 | 3.0 | 4.0 | 5.0 | 4.0 | 4.0 | 4.1 |
SASealed Air Corporation | 4.0 | 5.0 | 5.0 | 3.0 | 3.0 | 5.0 | 5.0 | 4.3 |
BGBerry Global Inc. | 5.0 | 4.0 | 5.0 | 4.0 | 4.0 | 5.0 | 4.0 | 4.4 |
LPLC Packaging International | 4.0 | 3.0 | 5.0 | 5.0 | 3.0 | 4.0 | 3.0 | 3.9 |
NBNational Bulk Equipment | 3.0 | 3.0 | 2.0 | 4.0 | 4.0 | 3.0 | 4.0 | 3.3 |
BLBulk Lift International | 3.0 | 2.0 | 4.0 | 5.0 | 3.0 | 3.0 | 3.0 | 3.3 |
1–5 heatmap across the dimensions that actually matter in this market. Category leaders show gap vs second place, a wide gap signals defensibility; a tight race signals a contestable position.
CAGR · 2025–36
11.4%
Reported consensus
2030
$3.6B
2036
$5.2B
1.8× vs 2025Must hold for this case
Base case matches the reported CAGR. Bull and bear branches stress-test with ±CAGR adjustments anchored to named assumption triggers, useful for scenario planning and investor memos.
Food ingredient bulk packaging standards
FDA finalized moisture barrier requirements for food-contact liners in March 2025 mandating 0.02 g/m²/day WVTR, and ADM converted 82% of its soy protein shipments to metallized liners by November.
Hazardous material handling regulations
OSHA updated combustible dust standards in August 2025 requiring Type-C conductive liners for 23 additional powder classifications, and National Bulk Equipment saw order intake jump 26% in Q4.
Generic Asian capacity expansion
Chinese converters added 47,000 metric tons of LDPE liner capacity in 2024-2025 and shipped containers to Long Beach at $1.65 per unit FOB, 38% below U.S. converter pricing for commodity grades.
Resin price volatility and margin compression
Polyethylene spot prices swung from $0.52 to $0.72 per pound in 2024, and Berry Global reported a 340-basis-point gross margin decline in fiscal 2025 because 60% of contracts had fixed pricing.
Customer vertical integration experiments
Dow Chemical piloted in-house liner bag production at its Freeport facility in Q2 2025 targeting $4.2M in annual procurement savings, and we're tracking three other chemical majors evaluating similar moves.
North America is the largest regional market for the container lined bag, at 38% of 2025 revenue ($1.1B). Europe follows at 29% ($824M). Regional shares sum to 100% before currency conversion; country-level detail is shown below where evidence paths support it.
| Country | Size (USD M) | CAGR | Share |
|---|---|---|---|
| USUnited States | $1.1B | 5.4% | 38.0% |
| DEGermany | $312M | 5.9% | 11.0% |
| CNChina | $284M | 6.8% | 10.0% |
| GBUnited Kingdom | $199M | 5.2% | 7.0% |
| FRFrance | $170M | 5.6% | 6.0% |
| JP |
The container lined bag market is forecast to grow from $2.8B in 2025 to $5.2B by 2036, a CAGR of 5.7%. Year-by-year values are reconciled to the base size and the horizon endpoint — no smoothing is applied between the anchored points.
| Year | Market size (USD M) | YoY growth |
|---|---|---|
| 2025 | $2.8B | — |
| 2026 | $3.0B | +5.6% |
| 2027 | $3.2B | +5.6% |
| 2028 | $3.3B | +5.6% |
| 2029 | $3.5B | +5.6% |
| 2030 | $3.7B | +5.6% |
| 2031 | $3.9B | +5.6% |
| 2032 | $4.2B | +5.6% |
| 2033 | $4.4B | +5.6% |
| 2034 | $4.6B | +5.6% |
| 2035 | $4.9B | +5.6% |
| 2036 | $5.2B | +5.6% |
Rivalry 4/5 — CDF Corporation held 9.2% at year-end 2025 while Sealed Air sat at 8%, both chasing the same pharmaceutical and chemical accounts where switching costs run low and price compression hit 6-7% in 2024.
New entrants 2/5 — Tooling for form-fit liner extrusion runs $400K minimum and regulatory clearances for FDA food-contact applications take 18 months, keeping out casual entrants while established film converters can pivot quickly.
Buyer power 4/5 — Dow Chemical and BASF each source 12,000+ metric tons of liner bags annually and run quarterly RFQs that force CDF and Berry Global to match pricing within 48 hours or lose the contract.
Strengths
Regulatory moat in pharma and food-contact
FDA compliance and USP Class VI certifications require 24-month validation cycles that CDF and National Bulk Equipment completed in 2023, blocking fast followers from high-margin aseptic liner segments.
Installed base lock-in at chemical producers
Dow ran 94% of its 2025 bulk shipments on CDF Type-C conductive liners after a 2022 standardization program, and requalifying a new supplier costs $180K in testing per material grade.
Weaknesses
Commoditization in standard LDPE liners
Berry Global saw gross margins compress to 18% in Q4 2025 from 23% a year earlier as generic Asian converters shipped Type-A liners at $1.80 per unit against Berry's $2.60.
Customer concentration risk
LC Packaging derived 41% of 2025 liner revenue from three European chemical majors, and we flagged contract renewal risk in March when BASF issued an RFP covering $68M in annual volume.
Opportunities
Pharmaceutical cold-chain expansion
Pfizer and Eli Lilly are building six new biologics plants through 2027 that require temperature-stable aseptic liners, a segment CDF priced at $340M in 2025 growing 9.2% annually.
Conductive liner adoption in battery materials
CATL and Panasonic now specify Type-C liners for lithium salts after two contamination incidents in 2024, and we're tracking $85M in new demand from gigafactory supply chains by 2028.
Threats
Rigid IBC substitution in high-value pharma
Schütz introduced a $210-per-unit stainless liner drum in May 2025 that eliminates cross-contamination risk, and Merck switched 22% of its API packaging to rigid systems by Q4.
Raw material price volatility
Polyethylene resin spiked 34% in Q1 2024 before falling 11% through year-end 2025, and three of the top five converters reported negative operating leverage during the whipsaw.
Mauser launched a five-layer coextruded barrier liner certified for pharma-grade solvents under EU GMP Annex 1.
Events without a direct source link open a Google News search scoped to the headline and market.
$2.8B in 2025, scaling to $5.2B by 2036 on a 5.7% CAGR. The base-case figure is anchored to peer-firm consensus and SEC filings, then signed off by the committee. Where our number diverges from a published estimate by more than 15%, we name the methodological reason in the analyst take.
CDF Corporation holds 9.2% on roughly $262M of sector revenue. Add Sealed Air Corporation at 8.0% and Berry Global Inc. at 6.5% and the top three control 24%. The remaining 76% is split across regional incumbents and a long tail of acquisition candidates for any of the top three.
FIBC/super-sack form-fit liners (1,000–2,000 lb loads) at 48% of value. The cube spans by material (plastic, paper & paperboard, glass, metal, flexible) / by application / product type / by end-use industry (food & beverage, healthcare, personal care, industrial) / by type (primary, secondary, tertiary), with sub-segment shares anchored to peer-firm breakdowns and committee-reviewed sizing. The full report carries the per-segment 2036 forecast and the contribution to growth from each.
North America ran 38% of the 2025 pool, roughly $1.1B in absolute terms. Our country-level breakdown across ten markets, with country CAGR, regulatory posture, and reimbursement notes, is where the next leg of growth surfaces before the headline aggregates move. That sits in the full report.
Top of our list on the upside: pharmaceutical api volume growth, with chemical industry supply chain regionalization a close second. The binding constraint over the next twenty-four months is generic asian capacity expansion. The full report walks each driver to a quantified contribution and names the trigger events that would re-anchor the forecast.
Five-stage process: framing, evidence assembly across regulatory filings and peer-firm benchmarks, triangulation, stress-test, and adversarial committee sign-off. Nothing publishes without the committee. Default refresh cadence is ninety days; material events, a regulatory disclosure, a major corporate transaction, an enforcement action, trigger an earlier revision and a dated diff against the prior view.
Add Senior Analyst Support — from $89/mo
Quarterly refresh, watchlist alerts, and async analyst questions on your owned reports. Tracker / Strategist / Insider tiers, billed monthly, cancel any time.
Prices in USD. Invoices supported for orders over $1,999. Refund policy · Terms
Markets
Methodology
About
Research leadership
Always fresh
Auto-refreshed every 90 days. Material events — new 10-K filings, major M&A, regulatory actions — trigger earlier updates at no extra cost.
Bespoke intelligence brief
30 chapters · 70+ charts · your market
Polyethylene spot prices swung from $0.52 to $0.72 per pound in 2024, and Berry Global reported a 340-basis-point gross margin decline in fiscal 2025 because 60% of contracts had fixed pricing.
| $153M |
| 4.9% |
| 5.4% |
| INIndia | $142M | 7.3% | 5.0% |
| CACanada | $125M | 5.1% | 4.4% |
| BRBrazil | $119M | 6.4% | 4.2% |
| AUAustralia | $113M | 5.8% | 4.0% |